Correlation Between CTi Biopharma and Cidara Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CTi Biopharma and Cidara Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CTi Biopharma and Cidara Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CTi Biopharma Corp and Cidara Therapeutics, you can compare the effects of market volatilities on CTi Biopharma and Cidara Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CTi Biopharma with a short position of Cidara Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of CTi Biopharma and Cidara Therapeutics.

Diversification Opportunities for CTi Biopharma and Cidara Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between CTi and Cidara is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding CTi Biopharma Corp and Cidara Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cidara Therapeutics and CTi Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CTi Biopharma Corp are associated (or correlated) with Cidara Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cidara Therapeutics has no effect on the direction of CTi Biopharma i.e., CTi Biopharma and Cidara Therapeutics go up and down completely randomly.

Pair Corralation between CTi Biopharma and Cidara Therapeutics

If you would invest  2,343  in Cidara Therapeutics on December 24, 2024 and sell it today you would earn a total of  20.00  from holding Cidara Therapeutics or generate 0.85% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

CTi Biopharma Corp  vs.  Cidara Therapeutics

 Performance 
       Timeline  
CTi Biopharma Corp 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days CTi Biopharma Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound forward indicators, CTi Biopharma is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Cidara Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Cidara Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Cidara Therapeutics may actually be approaching a critical reversion point that can send shares even higher in April 2025.

CTi Biopharma and Cidara Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CTi Biopharma and Cidara Therapeutics

The main advantage of trading using opposite CTi Biopharma and Cidara Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CTi Biopharma position performs unexpectedly, Cidara Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cidara Therapeutics will offset losses from the drop in Cidara Therapeutics' long position.
The idea behind CTi Biopharma Corp and Cidara Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals